IDL Biotech AB operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IDL Biotech AB with three other
pharmaceutical manufacturers in Europe:
Hemcheck Sweden AB
sales of 10,000.00 Swedish Kronor [US$1,184.00 ]
(1.86 million Euro [US$2.29 million]
of which 68%
was Licences), and
RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS
based in Turkey
(38.45 million Turkish Liras [US$9.43 million]
IDL Biotech AB reported sales of SEK 32.31 million (US$3.83 million)
December of 2017.
decrease of 3.5%
versus 2016, when the company's sales were SEK 33.49 million.